BRAF and Langerhans cell histiocytosis: A major breakthrough in the LCH puzzle came with discovery of recurrent somatic BRAF V600E gene mutations in histiocytes in 50% of LCH lesions, 13 of which have been validated in multiple subsequent studies [122].